Understanding the biological mechanisms that drive cancer initiation, progression, metastasis, and treatment resistance is essential for developing new therapeutic strategies. This session examines cancer-cell biology together with the complex interactions among tumor cells, immune cells, stromal components, signaling pathways, metabolism, and the surrounding tumor microenvironment.
Abstract Scope and Participation
Submissions may address cancer cell biology, tumor microenvironment, cancer stem cells, metabolism, signaling pathways, tumor heterogeneity, invasion, metastasis, cell death, progression, and resistance mechanisms. Basic scientists, translational researchers, molecular biologists, immunologists, and oncology researchers are invited to participate.







Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States